Kenya Medical Research Institute, Centre for Clinical Research, P.O. Box 54840 00200, Off Mbagathi Road, Nairobi, Kenya.
Kenya Medical Research Institute, Centre for Public Health Research, P.O. Box 54840 00200, Off Mbagathi Road, Nairobi, Kenya.
BMC Psychiatry. 2019 May 7;19(1):137. doi: 10.1186/s12888-019-2118-3.
Khat is an amphetamine like psychostimulant chewed by over 10 million people globally. Khat use is thought to increase the risk of psychosis among its chewers. The evidence around this however remains inconclusive stemming from the scanty number of studies in this area and small study sample sizes. We undertook a large household survey to determine the association between psychotic symptoms and khat chewing in a rural khat growing and chewing population in Kenya.
For this cross-sectional household survey, we randomly selected 831 participants aged 10 years and above residing in the Eastern region of Kenya. We used the psychosis screening questionnaire (PSQ) to collect information on psychotic symptoms and a researcher designed sociodemographic and clinical questionnaire to collect information on its risk factors. We used descriptive analysis to describe the burden of khat chewing and other substance use as well as rates and types of psychotic symptoms. Using a univariate and multivariate analyses with 95% confidence interval, we estimated the association between khat chewing and specific psychotic symptoms.
The prevalence of current khat chewing in the region was at 36.8% (n = 306) with a male gender predominance (54.8%). At least one psychotic symptom was reported by 16.8% (n = 168) of the study population. Interestingly, psychotic symptoms in general were significantly prevalent in women (19.5%) compared to men (13.6%) (p = 0.023). Khat chewing was significantly associated with reported strange experiences (p = 0.024) and hallucinations (p = 0.0017), the two predominantly reported psychotic symptoms. In multivariate analysis controlling for age, gender, alcohol use and cigarette smoking, there was a positive association of strange experiences (OR, 2.45; 95%CI, 1.13-5.34) and hallucination (OR, 2.08; 95% C.I, 1.06-4.08) with khat chewing. Of note was the high concurrent polysubstance use among khat chewers specifically alcohol use (78.4%) and cigarette smoking (64.5%).
Psychotic symptoms were significantly elevated in khat users in this population. Future prospective studies examining dose effect and age of first use may establish causality.
阿拉伯茶是一种安非他命类兴奋剂,全球有超过 1000 万人咀嚼。咀嚼阿拉伯茶被认为会增加咀嚼者出现精神病的风险。然而,由于该领域研究数量稀少且研究样本量较小,相关证据仍不明确。我们在肯尼亚一个种植和咀嚼阿拉伯茶的农村地区进行了一项大型家庭调查,以确定精神病症状与咀嚼阿拉伯茶之间的关联。
在这项横断面家庭调查中,我们随机选择了 831 名年龄在 10 岁及以上居住在肯尼亚东部地区的参与者。我们使用精神病筛查问卷(PSQ)收集精神病症状信息,以及研究人员设计的社会人口统计学和临床问卷收集其风险因素信息。我们使用描述性分析来描述阿拉伯茶咀嚼和其他物质使用的负担以及精神病症状的发生率和类型。使用单变量和多变量分析(95%置信区间),我们估计了阿拉伯茶咀嚼与特定精神病症状之间的关联。
该地区目前阿拉伯茶的流行率为 36.8%(n=306),男性占主导地位(54.8%)。研究人群中至少有一种精神病症状的报告率为 16.8%(n=168)。有趣的是,一般来说,女性(19.5%)精神病症状的报告率明显高于男性(13.6%)(p=0.023)。在控制年龄、性别、饮酒和吸烟的多变量分析中,咀嚼阿拉伯茶与报告的奇怪体验(p=0.024)和幻觉(p=0.0017)呈正相关,这是两种主要报告的精神病症状。
在该人群中,咀嚼阿拉伯茶者的精神病症状明显升高。未来的前瞻性研究检查剂量效应和首次使用年龄可能会确定因果关系。